rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
24
|
pubmed:dateCreated |
2008-6-13
|
pubmed:abstractText |
This study evaluated whether a xanthine oxidase (XO) inhibitor, oxypurinol, produces clinical benefits in patients with New York Heart Association functional class III to IV heart failure due to systolic dysfunction receiving optimal medical therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1558-3597
|
pubmed:author |
pubmed-author:BrownJoanneJ,
pubmed-author:ColucciWilson SWS,
pubmed-author:FisherCharlesCJr,
pubmed-author:FreudenbergerRonaldR,
pubmed-author:GivertzMichael MMM,
pubmed-author:HareJoshua MJM,
pubmed-author:LiuPeterP,
pubmed-author:MangalBrianB,
pubmed-author:MannDouglas LDL,
pubmed-author:OPT-CHF Investigators,
pubmed-author:SchwarzRichard PRP
|
pubmed:issnType |
Electronic
|
pubmed:day |
17
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2301-9
|
pubmed:dateRevised |
2009-6-24
|
pubmed:meshHeading |
pubmed-meshheading:18549913-Adolescent,
pubmed-meshheading:18549913-Adult,
pubmed-meshheading:18549913-Aged,
pubmed-meshheading:18549913-Aged, 80 and over,
pubmed-meshheading:18549913-Double-Blind Method,
pubmed-meshheading:18549913-Enzyme Inhibitors,
pubmed-meshheading:18549913-Female,
pubmed-meshheading:18549913-Health Status Indicators,
pubmed-meshheading:18549913-Heart Failure,
pubmed-meshheading:18549913-Humans,
pubmed-meshheading:18549913-Male,
pubmed-meshheading:18549913-Middle Aged,
pubmed-meshheading:18549913-Natriuretic Peptide, Brain,
pubmed-meshheading:18549913-Oxypurinol,
pubmed-meshheading:18549913-Quality of Life,
pubmed-meshheading:18549913-Questionnaires,
pubmed-meshheading:18549913-Systole,
pubmed-meshheading:18549913-Uric Acid,
pubmed-meshheading:18549913-Xanthine Oxidase
|
pubmed:year |
2008
|
pubmed:articleTitle |
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.
|
pubmed:affiliation |
The University of Miami Miller School of Medicine, Miami, Florida v, USA. jhare@med.miami.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|